P. Carter

Radiology, Nuclear Medicine and Imaging · 2001–2017

A researcher in the Science corpus: 4 papers; trusts 7 researchers and is trusted by 10 researchers here, as inferred from the citation graph.

Subfields

• Radiology, Nuclear Medicine and Imaging — 65 citations into it; #709 of 3,265 by trust here, #892 by citations
• Molecular Biology — 55 citations into it; #4,454 of 17,773 by trust here, #9,136 by citations
• Immunology — 43 citations into it
• Oncology — 40 citations into it; #235 of 1,698 by trust here, #892 by citations
• Genetics — 18 citations into it

Whom P. Carter trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. G. A. Lazar
2. R. Jefferis
3. H. Hoogenboom
4. T. Waldmann
5. G. Walsh
6. Padmanee Sharma
7. P. Senter

Who trusts P. Carter overall

1. R. Jefferis
2. K. Imai
3. A. Chan
4. W. Hurley
5. Pietro Sormanni
6. Tong Li
7. A. Takaoka
8. Ron J. Keizer
9. J. C. Roberts
10. Theresa M. Allen

Papers from P. Carter's perspective

Ordered by how strongly the researchers P. Carter trusts endorse each paper. Same corpus, a different order for every researcher.

1. Potent antibody therapeutics by design (Nature reviews. Immunology)
2. Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcgammaRIIIa gene. (Blood)
3. Two immunoglobulin G fragment C receptor polymorphisms independently predict response to rituximab in patients with follicular lymphoma. (Journal of Clinical Oncology)
4. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. (New England Journal of Medicine)
5. Arming antibodies: prospects and challenges for immunoconjugates (Nature Biotechnology)
6. Engineered antibody Fc variants with enhanced effector function.
7. Monoclonal antibody successes in the clinic (Nature Biotechnology)
8. The Absence of Fucose but Not the Presence of Galactose or Bisecting N-Acetylglucosamine of Human IgG1 Complex-type Oligosaccharides Shows the Critical Role of Enhancing Antibody-dependent Cellular… (Journal of Biological Chemistry)
9. Lack of Fucose on Human IgG1 N-Linked Oligosaccharide Improves Binding to Human FcγRIII and Antibody-dependent Cellular Toxicity* (Journal of Biological Chemistry)
10. Tumor Regression in Cancer Patients by Very Low Doses of a T Cell–Engaging Antibody (Science)

Their papers

• Potent antibody therapeutics by design (2006) — 1,121 citations
• Next generation antibody drugs: pursuit of the 'high-hanging fruit' (2017) — 704 citations
• Therapeutic antibodies for autoimmunity and inflammation (2010) — 847 citations
• Improving the efficacy of antibody-based cancer therapies (2001) — 881 citations